Historical Stock Price
ETFs Holding CBAY »    Stock Splits Calendar »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
06/14/2021 $4.78 $5.06 $4.78 $4.90 921.90K
06/15/2021 $4.95 $4.95 $4.71 $4.89 840.60K
06/16/2021 $4.85 $4.92 $4.68 $4.79 691.50K
06/17/2021 $4.80 $4.94 $4.78 $4.92 548.60K
06/18/2021 $4.87 $4.89 $4.58 $4.63 834.30K
CymaBay Therapeutics is a biopharmaceutical company focused on developing and providing access to therapies for patients with liver and other diseases. Co.'s pipeline includes two clinical stage product candidates: seladelpar (MBX-8025), which is a selective agonist for the peroxisome proliferator-activated receptor delta and has the potential to treat certain diseases of the liver and disorders of lipid metabolism; and MBX-2982, which targets G protein-coupled receptor 119, a receptor that interacts with bioactive lipids known to stimulate glucose-dependent insulin secretion. Co. has one preclinical stage product candidate, CB-001, which targets G protein-coupled receptor 120.
CBAY historical stock prices picture
CymaBay Therapeutics (CBAY) has the following price history information. Looking back at CBAY historical stock prices for the last five trading days, on June 14, 2021, CBAY opened at $4.78, traded as high as $5.06 and as low as $4.78, and closed at $4.90. Trading volume was a total of 921.90K shares. On June 15, 2021, CBAY opened at $4.95, traded as high as $4.95 and as low as $4.71, and closed at $4.89. Trading volume was a total of 840.60K shares. On June 16, 2021, CBAY opened at $4.85, traded as high as $4.92 and as low as $4.68, and closed at $4.79. Trading volume was a total of 691.50K shares. On June 17, 2021, CBAY opened at $4.80, traded as high as $4.94 and as low as $4.78, and closed at $4.92. Trading volume was a total of 548.60K shares. On June 18, 2021, CBAY opened at $4.87, traded as high as $4.89 and as low as $4.58, and closed at $4.63. Trading volume was a total of 834.30K shares.

CBAY Historical Stock Prices By Date:

CBAY historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into CymaBay Therapeutics shares, starting with a $10,000 purchase of CBAY, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 02/03/2014
End date: 06/18/2021
Start price/share: $9.00
End price/share: $4.63
Dividends collected/share: $0.00
Total return: -48.56%
Average Annual Total Return: -8.62%
Starting investment: $10,000.00
Ending investment: $5,144.83
Years: 7.37
Date Close
06/14/2021$4.90
06/15/2021$4.89
06/16/2021$4.79
06/17/2021$4.92
06/18/2021$4.63
CBAY is categorized under the Healthcare sector; below are some other companies in the same sector:

CBIO Historical Stock Prices
CBLI Historical Stock Prices
CBM Historical Stock Prices
CBMG Historical Stock Prices
CBMX Historical Stock Prices
CBMXW Historical Stock Prices
CBPO Historical Stock Prices
CBRX Historical Stock Prices
CBST Historical Stock Prices
CBSTZ Historical Stock Prices

Also explore: CBAY shares outstanding history

CBAY Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.